Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery
Recruiting
- Conditions
- VV-ECMOThoracic SurgeryEmergency SurgeryARDSRetrospective CohortPropensity Score MatchingMortalityECMO Outcomes
- Registration Number
- NCT07016685
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Brief Summary
Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 380
Inclusion Criteria
- Adults ≥ 18 years
- VV-ECMO initiated during or after emergency thoracic surgery
- No opposition to data use
Exclusion Criteria
- Pregnant women
- Veno-Arterial ECMO patients
- Patients under legal protection
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 90-day all-cause mortality 90 days
- Secondary Outcome Measures
Name Time Method 90-day mortality in oncologic vs. non-oncologic thoracic surgery 90 days Postoperative complication rates 90 days Postoperative complication rates (hemorrhagic, thrombotic, infectious)
Trial Locations
- Locations (1)
CHRU Amiens
🇫🇷Amiens, France